Company Website: http://www.herborium.com/
Herborium Group, Inc., a botanical therapeutics ® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry, Botanical Drug Products (FDA Guidance 2004), to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredient based products in the areas of dermatology, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.